V1a vasopressin receptor expression is modulated during myogenic differentiation.
Neurohypophyseal peptides potently stimulate myogenic differentiation by acting through different receptors of the same family. Here, we show that L6C5 myogenic cells express, at a high density, a single class of V1a Arg8-vasopressin (AVP) receptor. The expression of the vasopressin receptor of type 1a (V1aR) is significantly higher in proliferating myoblasts than in differentiated myotubes. The differentiation-related decrease of V1aR expression was evident both at the mRNA and at the protein level as shown by the reduction of [(3)H]-AVP binding. However, in L6C5 cells transfected with a synthetic construct containing the luciferase gene driven by the 2 kb upstream region of V1aR, we observed a stimulation of the activity of the promoter when the cells were cultured in differentiative medium. The down-regulation of the V1aR correlated with a decreased half-life of its mRNA (half-life 5.86+/-0.74 hr in 10% fetal bovine serum [FBS] versus 3.53+/-0.72 hr in 1% FBS). Cyclosporine A and dexamethasone, but not 5'-azacytidine, treatments of cells in differentiation medium restored the V1aR level to that measured in proliferating L6C5 cells, thus confirming the role of post-transcriptional mechanisms in the modulation of V1aR expression. Taken together, these data show that mRNA stability plays a role in modulating protein expression during the myogenic differentiation process.
Alvisi
Monica
M
Dipartimento di Istologia ed Embriologia Medica Università di Roma La Sapienza Via Scarpa 16, 00161 Roma, Italy.
De Arcangelis
Valeria
V
Ciccone
Letizia
L
Palombi
Valeria
V
Alessandrini
Marta
M
Nemoz
Georges
G
Molinaro
Mario
M
Adamo
Sergio
S
Naro
Fabio
F
D000818:Animals; D001374:Azacitidine / Q000494:pharmacology; D001483:Base Sequence; D015152:Blotting, Northern; D002454:Cell Differentiation; D002478:Cells, Cultured; D016572:Cyclosporine / Q000494:pharmacology; D017931:DNA Primers; D003907:Dexamethasone / Q000494:pharmacology; D015870:Gene Expression / Q000187:drug effects; D006207:Half-Life; D007150:Immunohistochemistry; D009132:Muscles / Q000166:cytology* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D017483:Receptors, Vasopressin / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D017931:DNA Primers; D012333:RNA, Messenger; D017483:Receptors, Vasopressin; D003907:Dexamethasone; D016572:Cyclosporine; D001374:Azacitidine